Compared to α-TF, which had little effect in pancreatic cancer cells, δ-TT was efficient in augmenting gemcitabine activity, with a significant suppression of NF-κB activity and the expression of NF-κB transcriptional targets [81]. This evidence concerns the gene NFKB1 and pancreatic neoplasm.